Literature DB >> 27521569

Merkel cell polyomavirus infection and Merkel cell carcinoma.

Wei Liu1, Margo MacDonald1, Jianxin You2.   

Abstract

Merkel cell polyomavirus is the only polyomavirus discovered to date that is associated with a human cancer. MCPyV infection is highly prevalent in the general population. Nearly all healthy adults asymptomatically shed MCPyV from their skin. However, in elderly and immunosuppressed individuals, the infection can lead to a lethal form of skin cancer, Merkel cell carcinoma. In the last few years, new findings have established links between MCPyV infection, host immune response, and Merkel cell carcinoma development. This review discusses these recent discoveries on how MCPyV interacts with host cells to achieve persistent infection and, in the immunocompromised population, contributes to MCC development.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27521569      PMCID: PMC5102790          DOI: 10.1016/j.coviro.2016.07.011

Source DB:  PubMed          Journal:  Curr Opin Virol        ISSN: 1879-6257            Impact factor:   7.090


  65 in total

Review 1.  New insights into merkel cell carcinoma.

Authors:  Kenneth B Calder; Bruce R Smoller
Journal:  Adv Anat Pathol       Date:  2010-05       Impact factor: 3.875

2.  Merkel cell polyomavirus-infected Merkel cell carcinoma cells require expression of viral T antigens.

Authors:  Roland Houben; Masahiro Shuda; Rita Weinkam; David Schrama; Huichen Feng; Yuan Chang; Patrick S Moore; Jürgen C Becker
Journal:  J Virol       Date:  2010-05-05       Impact factor: 5.103

3.  Proliferative Merkel cells were not detected in human skin.

Authors:  I Moll; W Zieger; M Schmelz
Journal:  Arch Dermatol Res       Date:  1996-04       Impact factor: 3.017

4.  Transcriptome-wide studies of merkel cell carcinoma and validation of intratumoral CD8+ lymphocyte invasion as an independent predictor of survival.

Authors:  Kelly G Paulson; Jayasri G Iyer; Andrew R Tegeder; Renee Thibodeau; Janell Schelter; Shinichi Koba; David Schrama; William T Simonson; Bianca D Lemos; David R Byrd; David M Koelle; Denise A Galloway; J Helen Leonard; Margaret M Madeleine; Zsolt B Argenyi; Mary L Disis; Juergen C Becker; Michele A Cleary; Paul Nghiem
Journal:  J Clin Oncol       Date:  2011-03-21       Impact factor: 44.544

5.  Tumor infiltrating immune cells and outcome of Merkel cell carcinoma: a population-based study.

Authors:  Harri Sihto; Tom Böhling; Heli Kavola; Virve Koljonen; Marko Salmi; Sirpa Jalkanen; Heikki Joensuu
Journal:  Clin Cancer Res       Date:  2012-03-30       Impact factor: 12.531

6.  Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features.

Authors:  Michelle Heath; Natalia Jaimes; Bianca Lemos; Arash Mostaghimi; Linda C Wang; Pablo F Peñas; Paul Nghiem
Journal:  J Am Acad Dermatol       Date:  2008-03       Impact factor: 11.527

7.  Quantitation of human seroresponsiveness to Merkel cell polyomavirus.

Authors:  Diana V Pastrana; Yanis L Tolstov; Jürgen C Becker; Patrick S Moore; Yuan Chang; Christopher B Buck
Journal:  PLoS Pathog       Date:  2009-09-11       Impact factor: 6.823

8.  Merkel cell polyomavirus large T antigen disrupts host genomic integrity and inhibits cellular proliferation.

Authors:  Jing Li; Xin Wang; Jason Diaz; Sabrina H Tsang; Christopher B Buck; Jianxin You
Journal:  J Virol       Date:  2013-06-12       Impact factor: 5.103

9.  Identification of an overprinting gene in Merkel cell polyomavirus provides evolutionary insight into the birth of viral genes.

Authors:  Joseph J Carter; Matthew D Daugherty; Xiaojie Qi; Anjali Bheda-Malge; Gregory C Wipf; Kristin Robinson; Ann Roman; Harmit S Malik; Denise A Galloway
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-11       Impact factor: 11.205

10.  High-affinity Rb binding, p53 inhibition, subcellular localization, and transformation by wild-type or tumor-derived shortened Merkel cell polyomavirus large T antigens.

Authors:  Sophie Borchert; Manja Czech-Sioli; Friederike Neumann; Claudia Schmidt; Peter Wimmer; Thomas Dobner; Adam Grundhoff; Nicole Fischer
Journal:  J Virol       Date:  2013-12-26       Impact factor: 5.103

View more
  30 in total

1.  Cross-sectional associations between cutaneous viral infections and regulatory T lymphocytes in circulation.

Authors:  S S Hampras; M Tommasino; Y Zhao; J L Messina; A R Giuliano; N A Fenske; B Cherpelis; R S Hesterberg; A A Akuffo; R P Amorrortu; J Balliu; L Vijayan; T Gheit; P K Epling-Burnette; D E Rollison
Journal:  Br J Dermatol       Date:  2019-02-10       Impact factor: 9.302

2.  Merkel Cell Polyomavirus Infection of Animal Dermal Fibroblasts.

Authors:  Wei Liu; Nathan A Krump; Margo MacDonald; Jianxin You
Journal:  J Virol       Date:  2018-01-30       Impact factor: 5.103

Review 3.  Merkel cell carcinoma: Epidemiology, pathogenesis, diagnosis and therapy.

Authors:  Teresa Amaral; Ulrike Leiter; Claus Garbe
Journal:  Rev Endocr Metab Disord       Date:  2017-12       Impact factor: 6.514

Review 4.  Immune checkpoint inhibitors: new strategies to checkmate cancer.

Authors:  R A M Wilson; T R J Evans; A R Fraser; R J B Nibbs
Journal:  Clin Exp Immunol       Date:  2017-12-27       Impact factor: 4.330

Review 5.  Molecular Mechanisms of Merkel Cell Polyomavirus Transformation and Replication.

Authors:  Wei Liu; Jianxin You
Journal:  Annu Rev Virol       Date:  2020-06-30       Impact factor: 10.431

6.  Merkel Cell Polyomavirus Infection and Detection.

Authors:  Wei Liu; Nathan A Krump; Christopher B Buck; Jianxin You
Journal:  J Vis Exp       Date:  2019-02-07       Impact factor: 1.355

Review 7.  Mechanisms of persistence by small DNA tumor viruses.

Authors:  Nathan A Krump; Wei Liu; Jianxin You
Journal:  Curr Opin Virol       Date:  2018-10-01       Impact factor: 7.090

Review 8.  Molecular mechanisms of viral oncogenesis in humans.

Authors:  Nathan A Krump; Jianxin You
Journal:  Nat Rev Microbiol       Date:  2018-11       Impact factor: 60.633

9.  Selective reactivation of STING signaling to target Merkel cell carcinoma.

Authors:  Wei Liu; Gloria B Kim; Nathan A Krump; Yuqi Zhou; James L Riley; Jianxin You
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-01       Impact factor: 11.205

Review 10.  Merkel Cell Carcinoma from Molecular Pathology to Novel Therapies.

Authors:  Karolina Stachyra; Monika Dudzisz-Śledź; Elżbieta Bylina; Anna Szumera-Ciećkiewicz; Mateusz J Spałek; Ewa Bartnik; Piotr Rutkowski; Anna M Czarnecka
Journal:  Int J Mol Sci       Date:  2021-06-11       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.